The U.S. Food and Drug Administration is warning the public about criminals posing as FDA special agents and other law enforcement personnel as part of a continued international extortion scam.
Bushra Sumra's career highlights the profound impact that expertise in clinical research and regulatory compliance can have ...
Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon ...
The Food and Drug Administration had in April ... A Jan. 21 filing by the Office of Information and Regulatory Affairs, a White House agency, showed the proposal has been "withdrawn." ...
has been petitioning the FDA to ban formaldehyde in hair products since 2008, said Melanie Benesh, its vice president of government affairs. "Near the end of 2016, the FDA was prepared to ban it ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
The FDA recently submitted a proposed front-of-package labeling rule to the Office of Information and Regulatory Affairs. This proposed rule takes us one step closer to advancing a strong front-of ...
New Delhi: For blood cancer patients in India suffering from an advanced or relapsed form of the disease, another “living drug” has been cleared, nearly a year after the country’s apex drug regulator ...
Jan. 21, 2025 -- The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed. The drug ...
You are responsible for reading, understanding, and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy ...
The U.S. Food and Drug Administration has banned the use of red dye No. 3 in foods, more than three decades after researchers discovered its link to cancer in rodents and to worsened attention deficit ...
the Fall 2024 Unified Agenda of Regulatory and Deregulatory Actions issued by the Office of Management and Budget (OMB) in mid-December also provided an updated FDA proposal to issue a proposed ...